Search
World's first trial of new three-part children's cancer treatment
- OPACC
- Oct 10, 2018
- 1 min read
The study, involving doctors and cancer scientists in Southampton, America and Germany, will boost the body's immune system to kill off neuroblastoma, one of the most common childhood cancers.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...